Women who go into menopause before 40 are four times more likely to die young from cancer — and twice as likely to die young of heart disease or something else, a new study from Finland has found.
However, the researchers say that using hormone replacement therapy (HRT) for more than six months can cut the all-cause and cancer mortality risk by about half. They presented their findings Saturday at the 26th European Congress of Endocrinology in Stockholm.
“Various health risks of women with premature ovarian insufficiency have not been well recognized and the use of HRT is often neglected,” said Hilla Haapakoski, a PhD student at the University of Oulu, who led the study.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.